RLMD Stock Price
Relmada Therapeutics, Inc.
RLMD stock price is $3.20 (-1.23% on the day), giving Relmada Therapeutics, Inc. a market cap of $345.61M. Below are the price chart, the MarketXLS Rank, the company profile and the latest news.
RLMD Stock Overview
- Price
- $3.20
- Previous close
- $3.24
- Open
- $3.27
- Market cap
- $345.61M
- P/E ratio
- -6.0
- 52-week range
- $1.80 - $8.00
- 1-year price target
- $10.75
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Exchange
- NSC
- MarketXLS Rank
- 41
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing various products for the treatment of central nervous system diseases (CNS) and other disorders in the United States. Its lead product candidate is Esmethadone (d-methadone, dextromethadone, and REL-1017), a N-methyl-D-aspartate receptor antagonist which is in phase 3 clinical trial for the adjunctive or monotherapy treatment of major depressive disorder. The company is headquartered in Coral Gables, Florida.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RLMD | $3.20 | -1.2% | 908.62K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Relmada Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW